BASF’s Nutrition & Health division to focus on growth and increased competitiveness
Reduction of about 260 positions worldwide by end of 2015
BASF is implementing a series of measures within the nutrition & Health division to strengthen the competitiveness of its Performance Products segment. The Nutrition & Health division bundles BASF’s products and solutions for human and animal nutrition, the flavor and fragrance industry as well as the pharmaceutical industry.
BASF is adjusting its product portfolio in order to better meet changing consumer needs and regional demands. In Asia, BASF is building a citral plant with its partner Petronas to meet the growing demand of customers in the flavor and fragrance industry in the region. The first plants of the complex are expected to come on stream in 2016. At the same time, BASF will focus its production in the growing market of omega-3 fatty acids on the attractive market segment for highly concentrated omega-3 fatty acids and plans to sell the Norwegian Brattvåg site. BASF produces low concentrated omega-3 fatty acids at this site.
Marketing, sales and administration will be better adjusted to regional market dynamics. A global team responsible for marketing and innovation will in future support the development of customer-oriented products and solutions as well as faster market launches of new products. BASF aims to accelerate the innovation cycle of products for its customers through strategic partnerships.
Due to the planned measures about 260 positions in production, marketing and administration will be reduced globally by end of 2015. Consultations with the responsible employee representatives will be conducted.
“We aim to strengthen our position in the growing nutrition and health market. Through these measures we will adapt our business to better meet market and customer needs. At the same time, we will improve our profitability,” said Saori Dubourg, President of BASF’s Nutrition & Health division.
BASF continues to analyze further measures to strengthen the competitiveness of its Performance Products segment.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Scientists use copper nanowires to combat the spread of diseases

Lonely flies, like many humans, eat more and sleep less - COVID-19 lockdowns scrambled sleep schedules and stretched waistlines: One culprit may be social isolation itself

Scientists find inorganic food additives might make babies more vulnerable to allergies - Las nanopartículas inorgánicas podrían atravesar la barrera placentaria y llegar a la leche materna
Exonhit presents new opportunities in blood diagnostics in neurodegenerative diseases - Identification of new markers for BSE in collaboration with Roche Applied Science

Intuition and failure as valuable ingredients in chemical research - Methodology to collect lessons learned from partially failed trials and incorrect hypotheses

DNA repair: Opening the hatch to heal the break
ATP as trigger for targeted anti-cancer drug delivery
Society for Neuroscience - Washington, USA
Pronova BioPharma's PRC-4016 to begin clinical trials for mixed dyslipidemia
Novozymes and Prometic enter into alliance for purification of albumin-fusion proteins
